Widespread occurrence of neuro-active pharmaceuticals and metabolites in 24 Minnesota rivers and wastewaters

Science of the Total Environment

Volumn 461-462, Issue , 2013, Pages 519-527

  Writer, Jeffrey H ^a,b   Ferrer, Imma ^a   Barber, Larry B ^b   Thurman, E Michael ^a  

^a University of Colorado   (United States)

^b U S GEOLOGICAL SURVEY   (United States)

Author keywords

Anti depressant pharmaceuticals and metabolites; Environmental persistence; Time of flight mass spectrometry; Wastewater treatment; Water resources

Indexed keywords

ENVIRONMENTAL FATE; ENVIRONMENTAL ISSUES; ENVIRONMENTAL PERSISTENCES; STANDARD DEVIATION; TIME OF FLIGHT MASS SPECTROMETRY; TREATED WASTEWATER; WASTEWATER EFFLUENTS; WASTEWATER TREATMENT PLANTS;

AMIDES; DRUG PRODUCTS; EFFLUENTS; MASS SPECTROMETRY; METABOLITES; RIVERS; WASTEWATER TREATMENT; WATER RESOURCES;

BIOMOLECULES;

10 HYDROXY CARBAMAZEPINE; 10,11 DIHYDRO 10,11 DIHYDROXYCARBAMAZEPINE; 2 N GLUCURONIDE LAMOTRIGINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; DESMETHYL VENLAFAXINE; DRUG METABOLITE; ERYTHRO HYDROXYBUPROPION; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; N DESMETHYL CITALOPRAM; NORFLUOXETINE; OXCARBAZEPINE; RADAFAXINE; SURFACE WATER; THREO HYDROBUPROPION; UNCLASSIFIED DRUG; VENLAFAXINE;

CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL FATE; MASS SPECTROMETRY; METABOLITE; RIVER WATER; WASTEWATER; WATER POLLUTION;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG TRANSFORMATION; DRUG URINE LEVEL; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RIVER; TIME OF FLIGHT MASS SPECTROMETRY; UNITED STATES; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER ANALYSIS; WATER QUALITY; WATER SAMPLING;

ANTI-DEPRESSANT PHARMACEUTICALS AND METABOLITES; ENVIRONMENTAL PERSISTENCE; TIME-OF-FLIGHT MASS SPECTROMETRY; WASTEWATER TREATMENT; WATER RESOURCES;

CENTRAL NERVOUS SYSTEM AGENTS; CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MONITORING; MINNESOTA; MOLECULAR STRUCTURE; RIVERS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

MINNESOTA; UNITED STATES;

EID: 84878923900     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.04.099     Document Type: Article

References (40)

1. Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2008, 43:597-603.
2. Boxall A., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., et al. Pharmaceuticals and personal care products in the environment: what are the big questions?. Environ Health Perspect 2012, 120:1221-1229.
3. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A.J., Banks K.E., Johnson R.D., et al. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 2005, 24:464-469. [2005].
4. Celiz M.D., Tso J., Aga D.S. Pharmaceutical metabolites in the environment: analytical challenges and ecological risks. Environ Toxicol Chem 2009, 28:2473-2484.
5. Dalgaard L., Larsen C. Metabolism and excretion of citalopram in man: identification of acyl and N-glucuronides. Xenobiotica 1999, 29:1033-1041.
6. D'Ascenzo G., Dicorcia A., Gentili A., Mancini R., Nazzai M., Samperi R. Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci Total Environ 2003.
7. DeVane C.L. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999, 19:443-466.
8. Ferrer I., Thurman E.M. Identification of a new antidepressant and its glucuronide metabolite in water samples using liquid chromatography/quadrupole time-of-flight mass spectrometry. Anal Chem 2010, 82:8161-8168.
9. Ferrer I., Thurman E.M. Analysis of 100 pharmaceuticals and their degradates in water samples by liquid chromatography/quadropole time of flight mass spectrometry. J Chromatogr A 2012, 1259:148-157.
10. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., et al. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) untreated drinking water sources. Sci Total Environ 2008, 402:201-216.
11. Guler Y., Ford A.T. Anti-depressants make amphipods see the light. Aquat Toxicol 2010, 99:397-404.
12. Haas J., Kaplan C., Barenboim D., Jacob P., Benowitz N. Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use. Tob Control 2004, 13:52-56.
13. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J Hydrol 2002, 266:175-189.
14. Holčapek M., Kolářová L., Nobilis M. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal Bioanal Chem 2008, 391:59-78.
15. Hörsing M., Ledin A., Grabic R., Fick J., Tysklind M., Jansen J.C., et al. Determination of sorption of seventy-five pharmaceuticals in sewage sludge. Water Res 2011, 45:4470-4482.
16. 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man. Xenobiotica 1993, 23:349-359.
17. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res 2009, 43:363-380.
18. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
19. Kwon J.W., Armbrust K.L. Laboratory persistence and fate of fluoxetine inaquatic environments. Environ Toxicol Chem 2006, 25:2561-2568.
20. Lajeunesse A., Gagnon C., Gagné F., Louis S., Cejka P., Sauvé S. Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment-evidence of biological effects. Chemosphere 2011, 83:564-571.
21. Leclercq M., Mathieu O., Gomez E., Casellas C., Fenet H., Hillaire-Buys D. Presence and fate of carbamazepine, oxcarbazepine, and seven of their metabolites at wastewater treatment plants. Arch Environ Contam Toxicol 2009, 56:408-415.
22. Lee K.E., Langer S.K., Barber L.B., Writer J.H., Ferrey M.L., Schoenfuss H.L., et al. Endocrine active chemicals, pharmaceuticals, and other chemicals of concern in surface water, wastewater-treatment plant effluent, and bed sediment, and biological characteristics in selected streams, Minnesota-design, methods, and data. 2009: U S Geol Surv Data Ser 2011, 575. [54 pp., with appendixes].
23. López-Serna R., Jurado A., Vázquez-Suñé E., Carrera J., Petrović M., Barceló D. Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona. Spain Environ Pollut 2013, 203(174):305-315.
24. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., et al. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ Toxicol Chem 2010, 29:79-89.
25. Miao X.S., Yang J.J., Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ Sci Technol 2005, 39:7469-7475.
26. Miège C., Choubert J.M., Ribeiro L., Eusèbe M., Coquery M. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results. Water Sci Technol 2008, 57:49-56.
27. Nelson E.D., Do H., Lewis R.S., Carr S.A. Diurnal variability of pharmaceutical, personal care product, estrogen and alkylphenol concentrations in effluent from a tertiary wastewater treatment facility. Environ Sci Technol 2011, 45:1228-1234.
28. Painter M.M., Buerkley M.A., Julius M.L., Vajda A.M., Norris D.O., Barber L.B., et al. Antidepressants at environmentally relevant concentrations affect predator avoidance behavior of larval fathead minnows (Pimephales promelas). Environ Toxicol Chem 2009, 28:2677-2684.
29. Rantz S.E., et al. Measurement and computation of streamflow 1. Measurement and stream discharge. U S Geol Surv Water Supply Pap 1982, 2175:1-284.
30. Rantz S.E., et al. Measurement and computation of streamflow 2. Computation of discharge. U S Geol Surv Water Supply Pap 1982, 2175:285-631.
31. Reith D.M., Appleton D.B., Hooper W., Eadie M.J. The effect of body size on the metabolic clearance of carbamazepine. Biopharm Drug Dispos 2000, 21:103-111.
32. Rua-Gomez P.C., Püttmann W. Impact of wastewater treatment plant discharge of lidocaine, tramadol, venlafaxine and their metabolites on the quality of surface waters and groundwater. J Environ Monitor 2012, 14:1391-1399.
33. Schmidt D., Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav 2000, 1:396-405.
34. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ Sci Technol 2010, 44:1918-1925.
35. Schultz M.M., Painter M.M., Bartell S.E., Logue A., Furlong E.T., Werner S.L., et al. Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows. Aquat Toxicol 2011, 104:38-47.
36. Stagnitti M.N. Antidepressant use in the U.S. civilian non-institutionalized population 2002, Statistical Brief #77. May 2005, Agency for Healthcare Research and Quality, Rockville, MD, [Accessed Jan 2012 at terhttp://meps.ahrq.gov/mepsweb/data_files/publications/st77/stat77.pdf].
37. Tixier C., Singer H.P., Oellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 2003, 37:1061-1068.
38. U.S.Geological Survey Collection of water samples (ver. 2.0): U.S. geological survey techniques of water-resources investigations 2006, book 9, chap. A4, [accessed 6/2009 at http://pubs.water.usgs.gov/twri9A4/].
39. Vazquez-Roig P., Andreu V., Blasco C., Picó Y. Risk assessment on the presence of pharmaceuticals in sediments, soils and waters of the Pego-Oliva Marshlands (Valencia, eastern Spain). Sci Total Environ 2012, 44:24-32.
40. Zhang Y., Geissen S.U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.